HRT FINANCIAL LP

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1475597 NEW YORK, NY

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$40,645,369

+$39,707,999 QoQ

Shares Held

498,655

+577.7% QoQ

Ownership

0.353%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#43

of 490 holders

Holding Since

Dec 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $848,593,086 across 183 Biotechnology names. ARWR ranks #6 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc. This page	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$40,645,369	498,655	+577.7%	Shares	Defined	2026-08-14
2025-03-31	$937,370	73,577	-5.8%	Shares	Defined	2025-05-15
2024-12-31	$1,469,069	78,142	+41.3%	Shares	Defined	2025-02-14
2024-09-30	$1,071,064	55,295	+583.4%	Shares	Defined	2024-11-12
2023-12-31	$247,584	8,091	-45.9%	Shares	Defined	2024-02-09
2023-09-30	$402,028	14,962	-81.4%	Shares	Defined	2023-11-13
2023-06-30	$2,872,020	80,539	+408.3%	Shares	Defined	2023-08-11
2023-03-31	$402,488	15,846	-37.9%	Shares	Defined	2023-05-12
2022-06-30	$898,594	25,521	-23.4%	Shares	Defined	2022-08-12
2021-09-30	$2,078,981	33,301	-17.9%	Shares	Defined	2021-11-15
2021-06-30	$3,357,357	40,538	-38.3%	Shares	Defined	2021-08-16
2020-12-31	$5,037,247	65,649	—	Shares	Defined	2021-02-16
No filing history on record for this holder in this stock.